Anna Sureda Balari MD, PhD

Dr. Anna Sureda (MD, Ph.D.) graduated in Medicine and Surgery from the Universidad Autónoma de Madrid in 1986 and completed her residency in Hematology and Hemotherapy at the Ramón y Cajal Hospital in Madrid in 1990. In January 1991, she began working as a Hematology Consultant at the Clinical Hematology Unit of the Santa Creu I Sant Pau Hospital in Barcelona, ​​where she was later appointed Head of Ambulatory Care in 2002.

In January of 2011, Dr. Sureda moved to Cambridge, UK, where she obtained a position as a Senior Consultant in Lymphomas and the Transplantation of Hematopoietic Progenitors. Two years later she returned to Barcelona, where she works as Head of the Onco-Hematology Section and Hematology Service at the Dexeus University Hospital. Dr. Sureda spent four months at the University of Heidelberg, Germany, in 1990, and another four months at the Fred Hutchinson Cancer Research Center in Seattle (US) in 1993. She is currently the Head of the Clinical Hematology Service at the Catalan Institute of Oncology.

Dr. Sureda has focused her scientific career on clinical research in the treatment of patients with Hodgkin's lymphoma, non-Hodgkin's lymphoma, and multiple myeloma, evaluating new therapeutic strategies, including immunotherapy with the allogeneic transplantation of hematopoietic progenitors and targeted therapies.